Skip to main content


Table 2 Worldwide age-related prevalence of Parkinson’s disease

From: Is insulin-like growth factor-1 involved in Parkinson’s disease development?

Age-related prevalence of Parkinson’s disease
4–49 years3.26 per 10,000 person-years3.57 per 10,000 person-yearsHirsch et al. [21]
> 80 years103.48 per 10,000 person-years258.47 per 10,000 person-years
Age of Parkinson’s disease patients in countries with high prevalence of the disease 
CountryAge general populationReferences 
United States of America (USA)70.5Van Den Eeden [22] 
Japan68.7 ± 10.3Yamawaki et al. [26] 
Europe61.6 ± 9.73Pagano et al. [24] 
China58.7 ± 10.55Song et al. [25] 
Mexico56.9 ± 11.8Rodríguez-Violante et al. [23]